DOI:
10.1055/s-00000174
Augenheilkunde up2date
LinksClose Window
References
Carruthers MN, Topazian MD, Khosroshahi A. et al.
Rituximab vor IgG4-related diseas: A prospective, open-label trial.
Ann Rheum Dis 2015;
74: 1171-1177
doi:10.1136/annrehumdis-2014-206605
We do not assume any responsibility for the contents of the web pages of other providers.